Table 1.
Characteristics | Patients N, (%) | Median survival (months) | 5-year survival (%) | P |
---|---|---|---|---|
Age | .421 | |||
≤65 years | 156 (47) | 98 | 56 | |
>65 years | 179 (53) | NR | 60 | |
Sex | .220 | |||
Female | 82 (24) | 190 | 64 | |
Male | 253 (76) | 98 | 56 | |
Smoking status | .257 | |||
Never | 15 (5) | 19 | 43 | |
Previous | 105 (31) | 84 | 55 | |
Present | 215 (64) | NR | 60 | |
Performance status | .016 | |||
0 | 197 (59) | NR | 63 | |
1 | 120 (36) | 64 | 52 | |
2 | 18 (5) | 25 | 33 | |
Weight loss | .759 | |||
<10 % | 303 (90) | 190 | 58 | |
>10 % | 32 (10) | 98 | 57 | |
Histology | .028 | |||
Squamous cell carcinoma | 191 (57) | NR | 66 | |
Adenocarcinoma | 113 (34) | 54 | 46 | |
Large cell carcinoma | 31 (9) | 98 | 56 | |
Differentiation | <.001 | |||
Poor | 138 (41) | 47 | 47 | |
Moderate | 144 (43) | 190 | 65 | |
Well | 53 (16) | NR | 68 | |
Surgical procedure | 0.007 | |||
Wedge + Lobectomy | 243 (73) | 190 | 62 | |
Pneumectomy | 92 (27) | 37 | 47 | |
Pathological stage | <.001 | |||
pI | 157 (47) | NR | 72 | |
pII | 136 (41) | 62 | 51 | |
pIIIA | 42 (12) | 17 | 24 | |
Tumor stage | <.001 | |||
1 | 85 (25) | 190 | 75 | |
2 | 188 (56) | 84 | 57 | |
3 | 62 (19) | 25 | 37 | |
Nodal stage | <.001 | |||
0 | 232 (69) | NR | 67 | |
1 | 76 (23) | 35 | 43 | |
2 | 27 (8) | 18 | 18 | |
Surgical margins | .374 | |||
Free | 307 (92) | 190 | 59 | |
Not free | 28 (8) | 47 | 48 | |
Vascular infiltration | <.001 | |||
No | 284 (85) | 190 | 62 | |
Yes | 51 (15) | 27 | 33 |
NR, not reached; NCSLC, non-small cell lung cancer